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Purpose: The association between pulmonary vein (PV) dilatation and stroke in 
non-valvular atrial fibrillation (AF) patients remains unknown. Materials and 
Methods: We examined the left atrium (LA) and PV in control (n=138) and non-
valvular AF patients without (AF group, n=138) and with non-hemorrhagic stroke 
(AF with stroke group, n=138) using computed tomography. Results: The LA, LA 
appendage (LAA), and all PVs were larger in the AF than control patients. The or-
ifice areas of the LAA (5.6±2.2 cm2 vs. 4.7±1.7 cm2, p<0.001), left superior PV 
(3.8±1.5 cm2 vs. 3.4±1.2 cm2, p=0.019), and inferior PV (2.3±1.0 cm2 vs. 1.8±0.7 
cm2, p<0.001) were larger in the AF with stroke than in the AF only group. How-
ever, right PVs were not different between the two groups. In a multivariate analy-
sis, the orifice areas of the left superior PV [odds ratio (OR) 1.25, 95% confidence 
interval (CI) 1.03‒1.51, p=0.02], left inferior PV (OR 1.97, 95% CI 1.41‒2.75, 
p<0.001), and LAA (OR 1.30, 95% CI 1.13‒1.50, p<0.001) were independent pre-
dictors of stroke. Conclusion: Compared to the right PVs, the left PVs and LAA 
exhibited more significant enlargement in patients with AF and stroke than in pa-
tients with AF only. This finding suggests that the remodeling of left-sided LA 
structures might be related to stroke.
Key Words:   Atrial fibrillation, stroke, pulmonary veins, atrial appendage, multi-
detector computed tomography
INTRODUCTION
Atrial fibrillation (AF) is the most common cardiac abnormality associated with 
ischemic stroke.1,2 Cardiogenic cerebral embolism is responsible for approximately 
20% of all ischemic strokes. A number of other clinical features also increase the 
risk of stroke in patients with AF, including age, congestive heart failure (CHF), hy-
pertension, diabetes, and prior thromboembolism. Left ventricular dysfunction, left 
atrial (LA) size, mitral annular calcification, spontaneous echo contrast, and LA 
thrombus on echocardiography also increase the thromboembolic risk.3
Pulmonary veins (PVs) are important structures for the generation and mainte-
nance of AF and are the main targets of radiofrequency catheter ablation.4,5 In a pre-
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tients without stroke who underwent MDCT at the same 
period. The control group included 138 age-sex matched 
patients without AF and stroke who underwent concurrent 
MDCT. Similar to a previous study, only patients with non-
valvular AF who were not taking anticoagulants at the time 
of their stroke, or at the time of cardiac MDCT for patients 
without a history of stroke, were included.10
The CHADS2 (Congestive heart failure, Hypertension, 
Age >75, Diabetes mellitus, and prior Stroke or transient 
ischemic attack) and CHA2DS2-VASc (Congestive heart 
failure, Hypertension, Age >75, Diabetes mellitus, and pri-
or Stroke or transient ischemic attack, vascular disease, Age 
>65, female) scores of each patient were presented with 
and without points of stroke. CHF was defined as clinical 
heart failure (stage C or D) according to the 2009 Focused 
Update Incorporated into the ACC/AHA 2005 Guidelines 
for the Diagnosis and Management of Heart Failure in 
Adults.11 Hypertension was defined as systolic blood pres-
sure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg 
at two or more visits or past medical history of hyperten-
sion. AF was classified as paroxysmal AF when an episode 
of AF was self-terminating within 7 days and persistent AF 
when an AF episode either lasted longer than 7 days or re-
quired termination by cardioversion, either with drugs or by 
direct current cardioversion.12 
Cardiac MDCT
Contrast-enhanced cardiac CT scans were performed using 
a 64-slice MDCT (Somatom Sensation 64, Siemens Medi-
cal Solutions, Forchheim, Germany). A bolus of 60‒80 mL 
iopamidol (Iopamiro 370, Bracco, Italy) was injected into 
the antecubital vein at a flow rate of 5 mL/s, which was fol-
lowed by a 50-mL saline-chasing bolus at 5 mL/s. The start 
delay was defined as bolus tracking in the ascending aorta, 
and the scan was automatically initiated 5 seconds after 
reaching a threshold of 140 Hounsfield units. Scanning was 
performed using the following parameters: retrospective 
ECG-gated acquisitions, 80‒120 kVp, 500‒700 mAs de-
pending on patient size, and 64×0.6 mm slice collimation. 
Scans were performed from the tracheal bifurcation to the 
diaphragm. The field of view was adjusted according to the 
size of the heart. Cardiac CT scans were reconstructed at 
the end-systolic and mid-diastolic phases using a slice 
thickness of 0.75 mm, an increment interval of 0.5 mm, and 
a medium-smooth convolution kernel of B36f. We used 
end-systolic CT images for this study. 
Two radiologists (with four and eight years of experience 
vious report, PVs in patients with AF showed characteristic 
electrophysiological remodeling, including a lower mean 
voltage, slower conduction, and higher prevalence of com-
plex signals.6 The positive relationship between LA size 
and AF is well recognized.7 Herweg, et al.8 demonstrated 
that AF patients with hypertension had more prominent PV 
dilatation than patients in the control group, and patients 
with persistent AF had more increased PV ostial diameter 
than patients with paroxysmal AF. It is likely that impaired 
left ventricular diastolic function is associated with a 
stretch-induced PV arrhythmia. PV dilatation may be the 
crosslink between LA enlargement and AF.9 However, de-
spite the important role of PVs in the pathophysiology of 
AF, the association between PV remodeling and stoke in 
AF patients is poorly understood. This problem might be 
due to the limitations of current diagnostic tools. Notwith-
standing, the latest multidetector computed tomography 
(MDCT) technology permits cardiac scanning with high 
spatial and temporal resolution and provides precise mea-
surements (less than 1 mm) and three-dimensional informa-
tion. Specifically, this technology can be used to obtain reli-
able information on the diameter, cross-sectional area, and 
estimated volume of the LA and LA appendage (LAA).  
We hypothesized that specific features of PVs might be 
related to a higher stroke risk in patients with non-valvular 
AF. Accordingly, we analyzed the three-dimensional (3D) 
geometry and dimensions of LA structures, including PVs 
and LAA, using MDCT in AF and control patients. The pur-
pose of this study was to determine the characteristics of re-
modeling of the LA and PVs in AF patients with stroke, 
which is different than that in patients without stroke. Final-
ly, we also sought to determine if specific patterns and vari-
ants of PV anatomy might be predictive of stroke in non-
valvular AF.
MATERIALS AND METHODS
Patient sample
The study protocol was approved by the Institutional Re-
view Board of Severance Hospital, Seoul, Korea, and com-
plied with the tenets of the Declaration of Helsinki. All pa-
tients provided written informed consent. From February 
2008 to February 2011, 138 consecutive, non-hemorrhagic 
stroke with non-valvular AF patients who underwent cardi-
ac MDCT were enrolled (AF with stroke group). The AF 
group included 138 age-sex matched non-valvular AF pa-
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was used as a surrogate value for this area. 
PV dimensions change significantly between end systole 
and end diastole, and the ostia of the superior PVs are most 
vulnerable to dimensional inaccuracies. To overcome this 
problem, we used ECG-gated cardiac CT to provide a more 
precise method of PV dimensional measurement than non-
gated techniques.18 LAA morphology was evaluated using 
the method described by Di Biase, et al.19 Thrombus was 
defined as a filling defect with an oval or convex shape, and 
blood stasis was defined as a typical triangular filling defect 
at the ventral side of the LAA, which appeared as fluid-flu-
id levels.20
Statistical analysis
Normally distributed continuous variables were reported as 
mean±SD and compared with Student’s t-test. Categorical 
variables were reported as a percentage and compared with 
either Pearson’s chi square test or Fisher’s exact test. A 
multivariable logistic model was used to identify significant 
predictors of stroke. All potential confounders were entered 
into the model on the basis of known clinical relevance or 
significant associations observed in the univariate analysis. 
A receiver operating characteristic (ROC) curve was com-
puted for the completed prediction model, and we chose a 
in cardiac MDCT) calculated the LA and LAA volumes 
from CT images using imaging software (Vitrea, Toshiba, 
Japan). Each reader was blinded to the results of other ex-
aminations and to study groups. LA volumes were obtained 
by segmentation of the LA, and the software automatically 
calculated the volume. LA segmentation was performed us-
ing a semi-automatic approach by tracing the atrial contour 
to delete the pulmonary veins and the left ventricle in the 
3D configuration and multiplanar images. LAA volume 
was obtained using the same method. The LAA and PV ori-
fices were digitally transected by multi-planar reformatted 
(MPR) images.13,14 The pulmonary vein ostium was defined 
by the point of reflection of the parietal pericardium, as 
identified by intersection of tangents extending from the sur-
face of the PV and the wall of the adjacent LA.15-17 The LAA 
and PVs were first identified in the transverse MPR of the 
3D image and the image was reformatted along the center of 
the vein. The cross-sectional view of each vein was pro-
duced by creating a plane perpendicular to the transverse 
MPR image. This allowed for measurement of the short 
(D1) and long (D2) diameters of the LAA and PV orifices 
with electronic calipers in a plane perpendicular to the long 
axis of the LAA and PVs (Fig. 1). Because the LAA and PV 
orifices are elliptical in shape, a formula (0.785×D1×D2) 
Fig. 1. Multiplanar reconstructed (MPR) images illustrating the double-oblique measurements of pulmonary veins (PVs) and left atrial ap-
pendage (LAA) ostial diameters. (A) 3D reconstruction image of left atrium and pulmonary veins. The dotted line denotes right superior PV 
ostium. (B) Oblique MPR view of the right superior PV. The ostium (dotted line) was confirmed in multiple views. (C) Enlarged axial MPR 
view across the ostium of the superior PV showing measurements of the PV diameter (black arrows). (D) 3D reconstruction image of 
LAA. (E and F) MPR view of the LAA showing enlarged LAA. 3D, three-dimensional.
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echocardiography also showed progressive enlargement 
from control group to AF and stroke group. Interestingly, AF 
patients with stroke (5.6±2.2 cm2) had larger LAA orifice ar-
eas than the control (3.5±1.3 cm2, p<0.001) and AF only pa-
tients (4.7±1.7 cm2, p<0.001). The percentage of volume ra-
tio between LAA and LA in the AF with stroke group were 
larger than that of AF group (10.6±4.0% vs. 9.2±3.3%, 
p=0.011). These findings suggest progressive LA remodel-
ing from control to AF with stroke groups.
Differences in enlargement of the left and right PVs in 
AF patients with stroke
Orifice areas of the LAA were larger in the AF group (4.7± 
1.7 cm2) than the control group (3.5±1.3 cm2, p<0.001). The 
AF group also had larger orifice areas of all PVs than con-
trol patients. The orifice areas of the LAA (5.6±2.2 cm2 vs. 
4.7±1.7 cm2, p<0.001), left superior PV (3.8±1.5 cm2 vs. 
3.4±1.2 cm2, p=0.019), and inferior PV (2.3±1.0 cm2 vs. 
1.8±0.7 cm2, p<0.001) were larger in the AF with stroke 
group than the AF group. However, the orifice areas of the 
right PVs were not different between the AF only and the 
AF with stroke groups (Table 2, Fig. 2). We could not identi-
fy any differences in the LAA morphology between the 
three groups. There were no differences in PV type between 
the three groups.
probability threshold for predicting the likelihood of stroke. 
The Statistical Package for the Social Sciences (SPSS, 
SSPS Inc., Chicago, IL, USA) was used for all statistical 
evaluations. All p-values <0.05 were considered statistical-
ly significant. 
 
RESULTS
 
Patient characteristics
Patient demographic and clinical characteristics are pre-
sented in Table 1. Compared to age- and sex-matched AF 
patients without stroke, AF patients with stroke had a high-
er prevalence of persistent AF (34% vs. 59%, p<0.001) and 
hypertension (56% vs. 76%, p=0.001), as well as higher 
CHADS2 (1.4±1.1 vs. 1.7±0.9, p=0.006) and CHA2DS2-
VASc scores (1.8±1.2 vs. 2.1±1.1, p=0.014). 
Remodeling of the LA and LAA in AF patients with 
stroke
Table 2 shows a comparison of the LA, LAA, and PV fea-
tures measured by MDCT between patient groups. The mean 
LA volumes for the control, AF, and AF with stroke groups 
were 101±25 cm3, 143±43 cm3, and 163±53 cm3 (p<0.001), 
respectively. The LA dimensions measured by transthoracic 
Table 1. Patient Demographic and Clinical Characteristics
Control (n=138) p value* AF (n=138) p value†
AF with stroke 
(n=138)
Age, yrs 66±9 1.0 65±8 0.87 66±8
Female, n 45 (33%) 0.514 40 (29%) 0.436   46 (33%)
Persistent AF, n N/A 47 (34%) <0.001   81 (59%)
Comorbidities, n
    CHF 4 (3%) 0.356 7 (5%) 0.791   8 (6%)
    Hypertension 77 (56%) 1.0 77 (56%) 0.001 105 (76%)
    Age >75 yrs 26 (19%) 0.04 14 (10%) 0.839 13 (9%)
    Diabetes mellitus 31 (23%) 0.555 27 (20%) 0.119   38 (28%)
    Dyslipidemia 39 (28%) 0.123 28 (20%) 0.882   29 (21%)
CHADS2‡   1.35±0.95 1.0   1.36±1.05 0.006   1.72±0.88
CHADS2   1.35±0.95 1.0   1.36±1.05 <0.001   3.72±0.88
CHA2DS2-VASc‡   1.86±1.15 1.0   1.75±1.24 0.014   2.14±1.08
CHA2DS2-VASc   1.86±1.15 1.0   1.75±1.24 <0.001   4.14±1.08
BMI 24.0±2.9 0.595 24.5±2.8 0.213 23.8±3.1
LVEF, % 68.1±5.5 0.003 63.3±7.8 1.0   62.8±11.0
Aspirin use, n 55 (40%) <0.001 97 (70%) 0.517   92 (67%)
AF, atrial fibrillation; CHF, congestive heart failure; BMI, body mass index; LVEF, left ventricular ejection fraction; N/A, not applicable. 
*p-value of control vs. AF groups.
†p-value of AF vs. AF with stroke groups.
‡CHADS2 and CHA2DS2-VASc scores were calculated excluding points of stroke for stroke group.
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ing between patients with and without thrombus or blood sta-
sis of the LAA. Patients with thrombus or blood stasis were 
older (67.3±7.2 years vs. 65.1±7.6 years, p=0.04), had a 
higher prevalence of persistent AF (82% vs. 36%, p<0.001), 
higher CHADS2 scores (1.8±0.8 vs. 1.5±1.0, p=0.006), and 
higher CHA2DS2-VASc scores (2.3±1.0 vs. 1.8±1.2, p= 
0.004) than those without thrombus or blood stasis. LA vol-
ume (190.2±52.8 cm3 vs. 141.0±41.4 cm3, p<0.001), LAA 
Thrombus or blood stasis of LAA and left side PV 
enlargement 
For all 276 patients with AF, thrombus or blood stasis were 
observed in 20 (7.2%) and 42 (15.2%) patients, respectively. 
While thrombus or blood stasis were observed in 51 (37.0%) 
AF patients with stroke, these complications were found in 
only 11 (8.0%) patients in the AF group (p<0.001). Table 3 
shows a comparison of the clinical features and LA remodel-
Table 2. Comparisons of Pulmonary Vein Features Measured by MDCT 
Control (n=138) p value* AF (n=138) p value†
AF with stroke 
(n=138)
Volumes 
    LA volume, cm3 101±25 <0.001 143±43 0.002 163±53
    LAA volume, cm3   8.7±3.4 <0.001 12.9±5.4 <0.001 17.0±8.8
    LAA/LA volume, %   8.7±2.6 0.756   9.2±3.3 0.011 10.6±4.0
LA dimensions (TTE)
    Anterior-posterior, mm 36.2±5.6 <0.001 41.4±5.9 <0.001 46.2±7.4
    Medial-lateral, mm 37.8±4.3 0.005 48.4±7.5 0.011 58.2±6.6
    Superior-inferior, mm 50.4±4.4 0.004 63.0±9.3 0.034 72.5±7.4
Orifice area, cm2 
    LAA   3.5±1.3 <0.001   4.7±1.7 <0.001   5.6±2.2
    LSPV   2.7±0.9 <0.001   3.4±1.2 0.019   3.8±1.5
    LIPV   1.6±0.5 0.012   1.8±0.7 <0.001   2.3±1.0
    RSPV   3.1±1.1 <0.001   4.0±1.3 0.245   3.7±1.4
    RIPV   2.3±0.8 <0.001   2.8±1.0 0.98   2.7±1.1
LAA morphology
    Chicken-wing type 70 (51%) 0.398 77 (56%) 0.464   83 (60%)
PV morphology
    Common LPV 8 (6%) 0.802 9 (7%) 0.812 10 (7%)
    Accessory RPV 20 (15%) 0.333 26 (19%) 0.333   20 (15%)
LA, left atrium; LAA, left atrial appendage; TTE, transthoracic echocardiography; AF, atrial fibrillation; MDCT, multidetector computed tomography; LSPV, 
left superior pulmonary vein; LIPV, left inferior pulmonary vein; RSPV, right superior pulmonary vein; RIPV, right inferior pulmonary vein; LPV, left pulmonary 
vein; RPV, right pulmonary vein.
*p-value of control vs. AF groups.
†p-value of AF vs. AF with stroke groups.
Fig. 2. Comparison of LA volume (A) and orifice area of the LAA and PVs (B) between the three patient groups. LA, left atrium; LAA, left atrial appendage; 
LSPV, left superior pulmonary vein; LIPV, left inferior pulmonary vein; RSPV, right superior pulmonary vein; RIPV, right inferior pulmonary vein.
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of stroke with LA volume (per 10 cm3, OR 1.16, 95% CI 
1.09‒1.23, p<0.001) and thrombus or blood stasis seen on 
MDCT (OR 11.94, 95% CI 5.95‒23.98, p<0.001). When the 
orifice areas were accounted for individual components of 
CHA2DS2-VASc score and the presence of thrombus or 
blood stasis on MDCT, ostial areas of left side structures, i.e., 
LAA, LSPV, and LIPV, were still independent risk factors of 
stroke but ostial areas of right side structures were not.
In the ROC curve analysis, LAA orifice area, LA vol-
ume, LIPV orifice area, and LSPV orifice area predicted 
stroke in AF patients with area under the curves of 0.739, 
0.720, 0.674, and 0.587, respectively (Fig. 3).
DISCUSSION
Major findings
The main finding of this study was significant dilation of 
the left PVs and the LAA in AF patients with stroke. How-
ever, similar findings could not be demonstrated in the right 
volume (17.1±8.0 cm3 vs. 13.9±6.8 cm3, p=0.01), and the left 
superior (4.1±1.8 cm2 vs. 3.5±1.2 cm2, p=0.007) and inferior 
PV orifices (2.5±1.2 cm2 vs. 2.0±0.8 cm2, p=0.003) were 
larger in patients with thrombus or stasis of the LAA. How-
ever, the orifice areas of the right superior and inferior PVs 
showed no differences between two groups. 
Multiple logistic regression analysis of risk factors for 
stroke                                                         
Multiple possible clinical predictors and CT measurements 
were assessed as univariate and multivariate risk factors for 
stroke (Table 4). The significant univariate risk factors of 
stroke were hypertension, diabetes mellitus, persistent AF, 
thrombus or blood stasis on MDCT, higher CHADS2 and 
CHA2DS2-VASc score, larger LA volume, and larger LAA, 
LSPV, and LIPV orifice areas. When adjusted for CHA2DS2-
VASc score, the orifice areas of the left superior PV (OR 
1.55, 95% CI 1.31‒1.84, p<0.001), the left inferior PV (OR 
2.66, 95% CI 1.96‒3.61, p<0.001), and the LAA (OR 1.53, 
95% CI 1.35‒1.74, p<0.001) were independent risk factors 
Table 3. Thrombus or Blood Stasis of the LAA and Left PV Enlargement in Patients with AF
No thrombus or blood stasis (n=214) Thrombus or blood stasis (n=62) p value
Age, yrs 65.1±7.6 67.3±7.2 0.043
Female gender   61 (28.5%) 25 (40.3%) 0.077
Persistent AF   77 (36.0%) 51 (82.3%) <0.001
Comorbidities, n
    CHF 11 (5.1%) 4 (6.5%) 0.751
    Hypertension 135 (63.1%) 47 (75.8%) 0.063
    Age >75 yrs 19 (8.9%)   8 (12.9%) 0.348
    Diabetes mellitus   49 (22.9%) 16 (25.8%) 0.635
    Dyslipidemia   42 (19.6%) 15 (24.2%) 0.434
    Stroke   87 (40.7%) 51 (82.3%) <0.001
    CHADS2*   1.5±1.0   1.8±0.8 0.006
    CHADS2   2.3±1.5   3.4±1.2 <0.001
    CHA2DS2-VASc*   1.8±1.2   2.3±1.0 0.004
    CHA2DS2-VASc   2.6±1.7   4.0±1.3 <0.001
LVEF, % 63.4±8.6   61.9±11.5 0.379
LA volume, cm3 141.0±41.4 190.2±52.8 <0.001
LAA volume, cm3 13.9±6.8 17.1±8.0 0.01
LAA/LA volume, %   9.9±3.7   9.1±3.5 0.218
Orifice area, cm2
    LAA   4.9±1.7   6.2±2.5 <0.001
    LSPV   3.5±1.2   4.1±1.8 0.007
    LIPV   2.0±0.8   2.5±1.2 0.003
    RSPV   3.8±1.3   3.8±1.6 0.906
    RIPV   2.7±1.0   2.9±1.3 0.153
AF, atrial fibrillation; CHF, congestive heart failure; LVEF, left ventricular ejection fraction; LA, left atrium; LAA, left atrial appendage; LSPV, left superior pul-
monary vein; LIPV, left inferior pulmonary vein; RSPV, right superior pulmonary vein; RIPV, right inferior pulmonary vein.
*CHADS2 and CHA2DS2-VASc scores before stroke for AF with stroke group.
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tions. Our study suggests that prominent anatomic remodel-
ing of the left LA structures may play an important role in 
the occurrence of stroke in AF patients. To the best of our 
knowledge, this is the first study to show more prominent 
structural remodeling of left-side structures such as LAA 
and left PVs than right PVs in non-valvular AF patients 
with stroke.
Remodeling of the LA and LAA in AF
It is well known that the relationship between LA chamber 
enlargement and AF is complex and that structural changes 
may lead to persistence of arrhythmia. The Framingham 
heart study showed that the relative risk for the subsequent 
development of stroke was 2.4 in men and 1.4 in women 
for every 10-mm increase in LA size.21 This finding is con-
sistent with the results of this study. Increased LA volume 
by every 10 cm3 was an independent risk factor of stroke in 
multivariate logistic analysis (OR 1.09, 95% CI 1.02‒1.17, 
p=0.014).
LAA is an important source of emboli in 70‒90% cases 
of AF.22-25 Embryologically, the LAA is a remnant of the 
primordial LA. The LAA lies anterior to the atrioventricular 
sulcus and is in close proximity to the left circumflex artery, 
PVs. Additionally, significant dilation of the left PVs and 
LAA was observed in AF patients with thrombus and blood 
stasis compared with those patients without these complica-
Table 4. Risk Factors of Stroke
Univariate OR 
(95% CI)
p value
Multivariate OR 
(95% CI)*
p value*
Multivariate OR 
(95% CI)‡
p value†
Age   1.02 (0.99‒1.04) 0.274 N/A N/A
Female gender   1.07 (0.70‒1.66) 0.75 N/A N/A
CHF   1.39 (0.54‒3.53) 0.494 N/A N/A
Hypertension   2.77 (1.76‒4.38) <0.001 N/A N/A
Persistent AF   2.75 (1.69‒4.49) <0.001   2.61 (1.59‒4.28) <0.001 1.86 (1.07‒3.24) 0.029
Diabetes mellitus   1.65 (1.03‒2.63) 0.036 N/A N/A
CHADS2 score‡   1.56 (1.26‒1.94) <0.001 N/A N/A
CHA2DS2-VASc‡   1.36 (1.14‒1.62) 0.001 N/A N/A
Blood stasis on MDCT   7.43 (3.53‒15.63) <0.001   6.72 (3.18‒14.22) 0.006 N/A
Thrombus on MDCT 40.89 (5.4‒308.86) <0.001 39.71 (5.24‒301.21) 0.001 N/A
Thrombus or blood stasis 
  on MDCT
12.91 (6.46‒25.83) <0.001 11.94 (5.95‒23.98) <0.001 N/A
LA volume, per 10 cm3   1.10 (1.03‒1.17) 0.004   1.16 (1.09‒1.23) <0.001 1.09 (1.02‒1.17) 0.014
LAA os area, cm2   1.55 (1.36‒1.76) <0.001   1.53 (1.35‒1.74) <0.001 1.46 (1.26‒1.69) <0.001
LSPV os area, cm2   1.25 (1.04‒1.50) 0.015   1.55 (1.31‒1.84) <0.001 1.40 (1.15‒1.69) 0.001
LIPV os area, cm2   2.11 (1.52‒2.92) <0.001   2.66 (1.96‒3.61) <0.001 2.27 (1.64‒3.15) <0.001
RSPV os area, cm2   0.86 (0.72‒1.03) 0.106   1.10 (0.94‒1.29) 0.214 1.05 (0.88‒1.26) 0.575
RIPV os area, cm2   0.90 (0.72‒1.13) 0.363   1.11 (0.90‒1.36) 0.320 0.95 (0.75‒1.21) 0.681
AF, atrial fibrillation; CHF, congestive heart failure; LA, left atrium; LAA, left atrial appendage; N/A, not applicable; MDCT, multidetector computed tomog-
raphy; LSPV, left superior pulmonary vein; LIPV, left inferior pulmonary vein; RSPV, right superior pulmonary vein; RIPV, right inferior pulmonary vein; OR, 
odds ratio; CI, confidence interval.
*Adjusted for CHA2DS2-VASc score.
†Adjusted for age, sex, CHF, hypertension, diabetes mellitus, and thrombus or blood stasis on MDCT.
‡CHADS2 and CHA2DS2-VASc scores before stroke for AF with stroke group.
Fig. 3. ROC curve analysis. The LAA orifice area, LA volume, LIPV orifice 
area, and LSPV orifice area predicted stroke in AF patients with area under 
the curves (AUCs) of 0.739, 0.720, 0.674, and 0.587, respectively. ROC, re-
ceiver operating characteristic; LAA, left atrial appendage; LA, left atrium; 
LSPV, left superior pulmonary vein; LIPV, left inferior pulmonary vein; RSPV, 
right superior pulmonary vein; RIPV, right inferior pulmonary vein.
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vented further enlargement in AF patients with stroke. Tsao, 
et al. found no enlargement of inferior PV ostia in chronic 
AF, compared to paroxysmal AF or control group. However, 
the number of patients in their chronic AF group was only 
eight; therefore, the lack of significance may be due to insuf-
ficient power due to the small sample size. In our study, all 
four PV ostia showed significant enlargement in chronic 
AF, compared with paroxysmal AF (Supplementary Table 
1, only online). This study is consistent with a previous 
study that reported PV enlargement in chronic AF. Addi-
tionally, this study showed that left PV and LAA enlarge-
ment is more common in AF patients with stroke than no-
stroke.
This study also showed that the average area of the supe-
rior PV is larger than the area of the inferior PV within each 
group. This finding is consistent with previous studies that 
reported simultaneous dilation of the superior PVs and LA 
enlargement in patients with paroxysmal AF and chronic 
AF .32,33 However, although the superior PVs were larger in 
those patients with AF,32,34 when this was adjusted with the 
concomitant increase in LA size, this difference was not 
significant.32
In this study, the RSPV and RIPV ostial areas were larger 
in persistent than paroxysmal AF. However, the RSPV and 
RIPV ostial areas were not different between patients with 
and without stroke. This finding might be related with con-
founding factors such as smaller body mass index and slight-
ly higher proportion of female patients in the stroke group.
Study limitations
Our study had several limitations. Although we found an 
association of increased ostial size of left side PVs and 
stroke, it is possible that the differences are reflective of in-
herent anatomical differences rather than structural remod-
eling. Because this study was performed as a case-control 
study, we could not show a progressive increase in the ori-
fice areas in the same AF patient group. It would be better if 
the changes in LAA and PV orifice diameters were evaluat-
ed by serial CT scan. Another issue is whether left atrial ap-
pendage and left pulmonary vein enlargement is caused by 
atrial fibrillation or whether it is related to hypertension, di-
astolic dysfunction, or other cardiovascular diseases that are 
prevalent in stroke patients. A more detailed, prospective 
study is needed to address these issues.
Conclusion
Compared with right PVs, the left PVs and LAA underwent 
the left phrenic nerve, and the left PVs.26,27 A study of post-
mortem and explanted hearts showed that atrial appendages 
from patients with atrial fibrillation have three times the vol-
ume of those in sinus rhythm.28 In this study, LAA dilation 
and enlargement of the LAA orifice were related to a higher 
risk of stroke. Previously, it was reported that the dilation of 
the LAA dimensions predict stroke in patients with AF.29 In 
our study, the LAA/LA ratio was significantly higher in pa-
tient with stroke than other groups (Table 2). Although the 
volume of both LA and LAA were larger in patient with 
thrombus/stasis, the ratio of LAA/LA was not significantly 
different between the two groups. However, previous studies 
demonstrated that the thrombus was not observed in 20‒40% 
of AF patients with recent thromboembolism.30
Recently, Di Biase, et al.19 reported that patients with 
Chicken Wing LAA morphology are less likely to have an 
embolic event, even after controlling for comorbidities and 
CHADS2 score. This result is consistent with our results in 
that stroke incidence is lower when there is less remodeling 
of the LAA. However, we could not find a relationship be-
tween stroke and LAA morphology. 
Prominent enlargement of left-sided LA structures in 
patients with stroke
In the AF group, atrial myocardium in the PVs was charac-
terized by more severe discontinuity, hypertrophy, and fi-
brosis.31 However, PV remodeling has not been fully eluci-
dated in AF patients with stroke. Interestingly, the ostia of 
left-sided PVs were larger in AF patients with stroke than in 
those without stroke. However, right-sided PVs showed no 
differences between the AF groups. Kim, et al.13 reported 
that the ostia of the left-sided PVs were more elliptical than 
right-sided PVs. Tsao, et al.32 investigated the change of PV 
by magnetic resonance angiography and showed that the 
diameter of LSPV was progressively enlarged from control 
group to paroxysmal AF and to chronic AF, but the diame-
ter of RSPV was not significantly different between parox-
ysmal AF and chronic AF. In our study, the stroke group 
had a significantly larger number of persistent AFs; there-
fore, LSPV areas were larger in the stroke group than the 
AF only group; meanwhile, RSPV area did not show a sig-
nificant difference between the two groups. The right supe-
rior PV passes behind the junction of the right atrium and 
the superior caval vein, and the inferior PV passes behind 
the intercaval area. Therefore, the orifices of the right PVs 
are directly adjacent to the plane of the atrial septum. These 
anatomic characteristics of the right PVs might have pre-
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Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 20141524
of Heart Failure in Adults A Report of the American College of 
Cardiology Foundation/American Heart Association Task Force 
on Practice Guidelines Developed in Collaboration With the Inter-
national Society for Heart and Lung Transplantation. J Am Coll 
Cardiol 2009;53:e1-90.
12. European Heart Rhythm Association; European Association for 
Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schot-
ten U, et al. Guidelines for the management of atrial fibrillation: 
the Task Force for the Management of Atrial Fibrillation of the 
European Society of Cardiology (ESC). Eur Heart J 2010;31: 
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15. Maeda S, Iesaka Y, Otomo K, Uno K, Nagata Y, Suzuki K, et al. 
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al. Effects of left atrial ablation of atrial fibrillation on size of the 
left atrium and pulmonary veins. Heart Rhythm 2004;1:576-81.
17. Schwartzman D, Lacomis J, Wigginton WG. Characterization of 
left atrium and distal pulmonary vein morphology using multidi-
mensional computed tomography. J Am Coll Cardiol 2003;41: 
1349-57.
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Hughes G, Roobottom CA. Pulmonary venous evaluation using 
electrocardiogram-gated 64-detector row cardiac CT. Br J Radiol 
2012;85:965-71.
19. Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, 
Gili S, et al. Does the left atrial appendage morphology correlate 
with the risk of stroke in patients with atrial fibrillation? Results 
from a multicenter study. J Am Coll Cardiol 2012;60:531-8.
20. Hur J, Kim YJ, Nam JE, Choe KO, Choi EY, Shim CY, et al. 
Thrombus in the left atrial appendage in stroke patients: detection 
with cardiac CT angiography--a preliminary report. Radiology 
2008;249:81-7. 
21. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. 
Left atrial size and the risk of stroke and death. The Framingham 
Heart Study. Circulation 1995;92:835-41.
22. Black IW, Hopkins AP, Lee LC, Walsh WF. Evaluation of trans-
esophageal echocardiography before cardioversion of atrial fibril-
lation and flutter in nonanticoagulated patients. Am Heart J 
1993;126:375-81.
23. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbo-
gen KA, et al. 2011 ACCF/AHA/HRS focused updates incorpo-
rated into the ACC/AHA/ESC 2006 guidelines for the manage-
ment of patients with atrial fibrillation: a report of the American 
College of Cardiology Foundation/American Heart Association 
Task Force on practice guidelines. Circulation 2011;123:e269-
367. 
24. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bush-
nell CD, et al. Primary prevention of ischemic stroke: a guideline 
from the American Heart Association/American Stroke Associa-
tion Stroke Council: cosponsored by the Atherosclerotic Peripher-
al Vascular Disease Interdisciplinary Working Group; Cardiovas-
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more significant ostial dilatation in patients with AF and 
stroke than in those with AF only. This finding suggests that 
remodeling of left-sided LA structures might be related 
with the occurrence of stroke.
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